Neogenomics (NEO) Revenue Growth (1y) (2011 - 2026)
Neogenomics (NEO) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 91.39% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 6.18% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 3.66% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.26% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 38.82% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 10.01% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 8.41% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 4.80% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.17% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | 11.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.09% |
| Dec 31, 2025 | 10.56% |
| Sep 30, 2025 | 11.90% |
| Jun 30, 2025 | 10.23% |
| Mar 31, 2025 | 7.55% |
| Dec 31, 2024 | 10.57% |
| Sep 30, 2024 | 10.44% |
| Jun 30, 2024 | 11.97% |
| Mar 31, 2024 | 13.86% |
| Dec 31, 2023 | 12.15% |
| Sep 30, 2023 | 17.99% |
| Jun 30, 2023 | 17.47% |
| Mar 31, 2023 | 17.11% |
| Dec 31, 2022 | 10.32% |
| Sep 30, 2022 | 6.13% |
| Jun 30, 2022 | 2.75% |
| Mar 31, 2022 | 1.42% |
| Dec 31, 2021 | -0.21% |
| Sep 30, 2021 | -3.27% |
| Jun 30, 2021 | 39.95% |